Search Ontology:
ChEBI
13,14-dihydro-15-keto-PGF2alpha
- Term ID
- CHEBI:63976
- Synonyms
-
- (5Z,9alpha,11alpha)-9,11-dihydroxy-15-oxoprost-5-en-1-oic acid
- 13,14-Dihydro-15-keto-pgf2alpha
- 13,14-dihydro-15-keto-Prostaglandin F2a
- 13,14-Dihydro-15-ketoprostaglandin F2alpha
- 15-Keto-13,14-dihydro-pgf2alpha
- 15-Keto-13,14-dihydroprostaglandin F2-alpha
- 15-Keto-13,14-dihydroprostaglandin F2alpha
- 9S,11S-dihydroxy-15-oxo-5Z-prostenoic acid
- dhk-PGF2alpha
- PGFM
- Definition
- A prostaglandin Fα obtained by formal oxidation of the 15-hydroxy group and hydrogenation of the 13,14-double bond of prostaglandin F2α.
- References
-
- cas:27376-76-7
- hmdb:HMDB0004685
- lipidmaps:LMFA03010027
- patent:US5397797
- pubmed:20961606
- pubmed:21228218
- pubmed:21615801
- pubmed:21653895
- pubmed:21741578
- pubmed:21924479
- pubmed:21940119
- pubmed:22192399
- reaxys:6227023
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from 13,14-dihydro-15-keto-PGF2alpha
Phenotype where environments contain 13,14-dihydro-15-keto-PGF2alpha
Phenotype modified by environments containing 13,14-dihydro-15-keto-PGF2alpha
Phenotype affecting 13,14-dihydro-15-keto-PGF2alpha
Human Disease Model